Medication info
Aprogen Rosuvastatin Calcium Tablet 5 Milligrams

Aprogen Rosuvastatin Calcium Tablet 5 Milligrams

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium Micronized›5.2mg / 1 tablet
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201800813 · Approved 2018.02.13 · Insurance code 645209620

Summary

Main use
Treatment of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease
Who uses it
Adults
Adult dosage
1. Primary hypercholesterolemia (type IIa), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease

  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Homozygous Familial Hypercholesterolemia
  • Hypercholesterolemia
  • Primary Dysbetalipoproteinemia
  • Coronary Heart Disease
  • Stroke
  • Myocardial Infarction
View approved original text

This medication is primarily used in patients with primary hypercholesterolemia and mixed dyslipidemia who are difficult to manage with diet and exercise alone. It is also effective as an adjunct to diet or other treatments in patients with homozygous familial hypercholesterolemia. It helps lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. Additionally, it is used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Particularly in patients at risk for cardiovascular diseases, it helps reduce the risk of cardiovascular events such as stroke and myocardial infarction and lowers the risk even after arterial revascularization. Therefore, this drug is used to improve dyslipidemia and reduce the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be used by patients who are allergic to certain components. Patients with active liver disease or significantly elevated liver enzyme levels should not take this medication. Patients with muscular disorders or severe renal impairment should also avoid this medication. Women who are pregnant or breastfeeding, and women of childbearing age who are not using adequate contraception should not use this medication. Women who may become pregnant should use this medication with caution after consulting a doctor. Patients at high risk of muscle-related side effects should not take high doses of this medication. Patients with genetic lactose intolerance should also refrain from using this medication. Patients who excessively consume alcohol or have a history of liver disease should undergo regular liver function tests when using this medication. If symptoms of muscle pain or weakness occur, medical attention should be sought immediately, and this medication should be discontinued if necessary. Patients in acute serious conditions should discontinue this medication, and it should be stopped if severe muscle weakness develops. This medication may increase the risk of muscle side effects when taken with certain drugs, so it is important to consult with a doctor regarding concurrent medications. Renal function tests may be required with high-dose usage. Asian patients may require dose adjustments due to increased drug exposure. This medication can be used in children and adolescents, but growth and development should be monitored. Rare side effects such as interstitial lung disease, severe liver damage, and severe skin reactions may occur, so any unusual symptoms should be reported to healthcare providers immediately. This medication may interact with other drugs, so it is important to inform the prescribing physician or pharmacist of all medications being taken. Do not use this medication during pregnancy or breastfeeding; women planning to become pregnant should use appropriate contraceptive methods. In case of overdose, as there are no specific antidotes, immediate hospital treatment should be sought. Dizziness may occur while taking this medication, so caution is advised when driving or operating machinery.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, Myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, licheniform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, decreased appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness safely for a longer period.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.